ZOE Science & Nutrition
ZOE Science & Nutrition

Davina McCall: Make this choice every day to reduce menopause symptoms

Half of the world’s population will go through menopause. Yet research shows that a large proportion of women do not feel informed and equipped for menopause. In this episode, we reveal the results of a brand new study that highlight the impact of diet on menopause symptoms. Davina McCall is a Briti

Featured Speakers

Davina McCall GuestSarah Berry Guest

Topics Discussed

Episode Summary

Executive Summary: The episode reframes menopause as a long, variable transition driven by fluctuating estrogen, not a single event. Davina McCall shares a candid lived experience of symptoms and recovery with HRT, while Sarah Berry presents new Zoe research showing symptom clusters, elevated chronic-disease risk, and that healthier eating plus activity can materially reduce symptom burden.

Main Topics: Lived experience of menopause and stigma (Priority: 5/5): Davina McCall describes the physical and psychological symptoms she experienced, how confusing and isolating they were, and how menopause has been historically silenced and stigmatized. Hormonal explanation and symptom variability (Priority: 5/5): Sarah Berry explains that estrogen receptors are widespread, so falling and fluctuating estrogen can produce more than 50 possible symptoms across mood, cognition, sleep, vasomotor, sexual, and physical domains. Menopause and long-term disease risk (Priority: 5/5): The discussion links peri/postmenopause with higher cardiometabolic risk, including blood pressure, cholesterol, inflammation, and glucose control changes, beyond symptom burden alone. HRT evidence and misinformation (Priority: 4/5): The speakers address lingering fear from older studies, explain differences between past oral HRT studies and current transdermal practice, and emphasize individualized medical advice. Diet as a symptom-reduction tool (Priority: 5/5): New Zoe data suggests healthier dietary patterns, especially Mediterranean-style changes, are associated with a substantial reduction in overall menopause symptom burden. Exercise, strength, and sedentary time (Priority: 4/5): Physical activity, especially cardiovascular and resistance training, is associated with fewer symptoms, while more sitting is linked to worse symptom burden. Research gaps and women’s health underfunding (Priority: 4/5): The conversation highlights how menopause and women’s health have been understudied and underfunded, with many prior trials focusing on men.

Key Arguments: Menopause is not one symptom or one moment; it is a long transition with highly variable symptoms across individuals and time. Fluctuating estrogen in perimenopause explains why symptoms can appear suddenly and unpredictably rather than in a linear decline. Menopause affects the whole body, not just reproduction, because estrogen receptors are present in many tissues. Menopause increases risk of chronic diseases such as cardiovascular disease and type 2 diabetes. Modern HRT evidence is more favorable than many people believe, especially compared with the outdated narratives from the Women's Health Initiative era. A healthier overall diet can reduce menopause symptom burden meaningfully, even without massive dietary overhauls. Dietary improvement appears beneficial even for women already using HRT, suggesting additive effects rather than replacement. More physical activity and less sedentary time are associated with fewer and less severe menopause symptoms. Women’s symptoms are often dismissed or misattributed, which delays effective treatment and worsens distress. Women’s health research has historically been neglected, contributing to misinformation and poor care pathways.

Data Points: Symptoms measured in Zoe study: 20 symptoms - Sarah Berry said the new analysis directly measured 20 symptoms, while acknowledging women can experience up to 50 overall. Women in Zoe cohort: 70,000 - Total peri- and postmenopausal women in the broader cohort used to study symptoms and biomarkers. Perimenopausal participants: 30,000 - Subset of the 70,000 women identified as perimenopausal. Postmenopausal participants: 40,000 - Subset of the 70,000 women identified as postmenopausal. Women with at least one symptom: 99.8% - Reported among peri- and postmenopausal women in the Zoe cohort. Women with 12 or more symptoms: 66% - Severity/count analysis of the 20 measured symptoms in the cohort. Symptom burden reduction with healthier diet: 34% - Observed over up to about 20 weeks in 5,000 perimenopausal women following Zoe dietary advice. Participants in diet study: 5,000 - Perimenopausal Zoe members followed longitudinally for dietary change and symptom change. Follow-up duration: 18 to 20+ weeks - Time over which symptom changes were tracked in the diet study. Estimated symptom duration: 2 to 5 years on average; up to 10 years - Sarah Berry described the perimenopausal phase and persistence of symptoms after menopause. Current age of menopause definition: 1 year after last menstruation - Used to define menopause rather than the start of symptoms. Chronic disease risk compared with men: Pre-menopausal women lower; post-menopausal women catch up or overtake - Described in relation to blood pressure, cholesterol, glucose control, and inflammation. Cardiovascular disease risk after menopause: At least 2x and up to 5x higher - Sarah Berry cited increased postmenopausal cardiovascular risk versus premenopausal levels. Women leaving jobs due to symptoms: 10% - A separate study mentioned during the discussion on functional impact. Women reporting distressing symptoms: 45% - Another study referenced as evidence of day-to-day impact. UK money wasted on hormone tests: £6 million/year - Estimate given for unnecessary private hormone testing in women. Research study type: Longitudinal observational data - Sarah Berry clarified the diet study was not a randomized controlled trial. Soy intake difference: About 70 times higher in East Asia than the UK - Used to support the discussion of soy isoflavones and lower symptom prevalence. Effective genistein threshold: >15 mg - Reported dose above which soy isoflavone supplements showed symptom reduction in trials.

Pivotal Quotes: "Women lose significance, importance, you become invisible, you are dried up, and life is over after menopause." — Davina McCall: Davina identified this as the biggest myth surrounding menopause. "99.8% of our peri and postmenopause women reported having one symptom or more." — Sarah Berry: This summarized the scale of symptom prevalence in the Zoe cohort. "A 34% reduction in overall menopause symptom burdens." — Sarah Berry: Sarah described the headline finding from the new diet study.

Implications: Listeners should treat menopause as a serious, multi-system health transition that deserves diagnosis, treatment, and lifestyle support. For industry and clinicians, it underscores the need for better education, more women-centered research, and practical access to evidence-based diet, exercise, and HRT guidance.

🔓 Sign Up for Unlimited Episode Search

About ZOE Science & Nutrition

View all episodes from ZOE Science & Nutrition